Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Myofibroblasts produce the fibrous scar in hepatic fibrosis. In the carbon tetrachloride (CCl(4)) model of liver fibrosis, quiescent hepatic stellate cells (HSC) are activated to become myofibroblasts. When the underlying etiological agent is removed, clinical and experimental fibrosis undergoes a remarkable regression with complete disappearance of these myofibroblasts. Although some myofibroblasts apoptose, it is unknown whether other myofibroblasts may revert to an inactive phenotype during regression of fibrosis. We elucidated the fate of HSCs/myofibroblasts during recovery from CCl(4)- and alcohol-induced liver fibrosis using Cre-LoxP-based genetic labeling of myofibroblasts. Here we demonstrate that half of the myofibroblasts escape apoptosis during regression of liver fibrosis, down-regulate fibrogenic genes, and acquire a phenotype similar to, but distinct from, quiescent HSCs in their ability to more rapidly reactivate into myofibroblasts in response to fibrogenic stimuli and strongly contribute to liver fibrosis. Inactivation of HSCs was associated with up-regulation of the anti-apoptotic genes Hspa1a/b, which participate in the survival of HSCs in culture and in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, restored RSPO3 expression during HSC deactivation52,53 or by therapeutic interventions might help to regain hepatocyte functions.”
From Hepatic stellate cells control liver zonation, size and functions via R-spondin 3 (2025) · cites this paper as [52]
In the citing paper
“Animal models reinforce the capacity of the injured liver to regress fibrosis and provide important platform for dissecting underlying mechanisms, although it should be noted that fibrosis in mice regresses incredibly rapidly, which may be in part attributed to the short duration of models (weeks to months in mice vs. years to decades in humans) and initiation of fibrosis at relatively young age (”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [262]
In the citing paper
“Fibroblast activation also involves increased activity of key glycolytic enzymes, such as hexokinase 2 and lactate dehydrogenase (LDH)47, which in turn increase cell proliferation47 and collagen synthesis48.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
In the citing paper
“During enhanced glycolysis, increased amounts of pyruvate are converted to acetyl-CoA in the mitochondrial matrix47 before entering the citric acid cycle. This yields intermediate metabolites, such as succinate, which promote fibrosis49.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [47]
Citations
Cites
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Self-citationBataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075 · cited 8×
“Myofibroblasts are aSMA collagen type I cells that are absent from the normal uninjured liver, rapidly emerge infibrotic liver to produce thefibrous scar, and completely disappear with regression of liver fibrosis (1, 2).”
BackgroundInfluentialThe role of matrix stiffness in regulating cell behavior†
Wells, R. G. (2008) · Hepatology · doi:10.1002/hep.22193 · Cited by 1,059
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
Winau, F., Hegasy, G., Weiskirchen, R., Weber, S., Cassan, C., Sieling, P. A., Modlin, R. L., Liblau, R. S., Gressner, A. M., & Kaufmann, S. H. E. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.011 · Cited by 410
Lee, C. G., Cho, S. J., Kang, M. J., Chapoval, S. P., Lee, P. J., Noble, P. W., Yehualaeshet, T., Lu, B., Flavell, R. A., Milbrandt, J., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040104 · Cited by 369
Cited by
Items 601–700 of 889
Research Progress of Fibroblast Growth Factor 21 in Fibrotic Diseases
Jia, M.-Q., Guan, C., Tao, J., & Zhou, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5042762 · Cited by 8
Role of platelet factor 4 in arteriovenous fistula maturation failure: What do we know so far?
Xiao, Y., Vázquez-Padrón, R. I., Martinez, L., Singer, H. A., Woltmann, D., & Salman, L. H. (2022) · The Journal of Vascular Access · doi:10.1177/11297298221085458 · Cited by 8
ETS1 suppresses hepatic stellate cell activation and liver fibrosis
Lee, W., Liu, X., Rosenthal, S. B., Miciano, C., Sakane, S., Hokutan, K., Dhar, D., Kim, H. Y., Brenner, D. A., & Kisseleva, T. (2025) · JCI Insight · doi:10.1172/jci.insight.195242 · Cited by 7
Self-citationBeyond hepatic stellate cell heterogeneity: Resolving fibrosis, restoring regeneration (Review)
Gao, C., Chen, G., Jia, H., Zhu, H., Cai, Y., Yang, D., & Zhao, K. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5733 · Cited by 8
Gratte, F. D., Pasic, S., Bakar, N. D. B. A., Gogoi-Tiwari, J., Liu, X., Carlessi, R., Kisseleva, T., Brenner, D. A., Ramm, G. A., Olynyk, J. K., et al. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105933 · Cited by 8
Self-citationPisciotta, A., Tinco, R. D., Bertani, G., Orlandi, G., Bertoni, L., Pignatti, E., Orciani, M., Sena, P., Bertacchini, J., Salvarani, C., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1196023 · Cited by 7
Clarity and Challenges in Tissue Fibrosis
Friedman, S. L. (2015) · Springer eBooks · doi:10.1007/978-4-431-55651-0_16 · Cited by 7
Vivoli, E., Maira, G. D., & Marra, F. (2016) · Current Pathobiology Reports · doi:10.1007/s40139-016-0103-9 · Cited by 7
Mitochondrial dysfunction attenuates rapid regeneration in livers with toxin-induced fibrosis
Li, Z., Liang, Y., Ying, H., Chen, M., He, X., Wang, Y., Tong, Y., & Cai, X. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4639 · Cited by 7
Elsayed, H. R. H., Abd-Elmonem, M. M., Gabr, O., & Badria, F.-E. (2015) · Benha Medical Journal · doi:10.4103/1110-208x.180324 · Cited by 7
Kent, T. L., & Custer, P. L. (2016) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000591 · Cited by 7
Lee, Y. A., & Friedman, S. L. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch36 · Cited by 7
Targeting cardiac fibroblasts: The pressure is on
Moore‐Morris, T., Pucéat, M., & Evans, S. Μ. (2014) · Cell Cycle · doi:10.4161/15384101.2014.954212 · Cited by 7
Self-citationNierath, W., Leitner, E., Reimann, S., Schwarz, R., Hinz, B., Bleich, A., Vollmar, B., & Zechner, D. (2024) · The FASEB Journal · doi:10.1096/fj.202400733r · Cited by 6
Tissue-specific Cre driver mice to study vascular diseases
Lyu, Q., & Fu, K. (2023) · Vascular Pharmacology · doi:10.1016/j.vph.2023.107241 · Cited by 6
Rapid liver self-recovery: A challenge for rat models of tissue damage
Calvillo-Robledo, A., Samson-Soleil, Marichal‐Cancino, B. A., Pizaño, M. Y. M., Ibarra-Martínez, D., Ventura‐Juárez, J., & Muñoz‐Ortega, M. H. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122975 · Cited by 6
Myofibroblasts in Normal and Fibrotic Liver in Different Animal Species
Kukolj, V. (2014) · Acta veterinaria · doi:10.2478/acve-2014-0038 · Cited by 6
GPRC5B promotes collagen production in myofibroblasts
Takizawa, N., Hironaka, T., Mae, K., Ueno, T., Horii, Y., Nagasaka, A., & Nakaya, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.05.035 · Cited by 6
Why Stress Matters: An Introduction
Tschumperlin, D. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_12 · Cited by 6
Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD
Dam, T. V., Toft, N. I., & Grøntved, L. (2022) · Cells · doi:10.3390/cells11050870 · Cited by 6
Sharma, A., Kudira, R., Wang, J., Miethke, A. G., & Gandhi, C. R. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30877 · Cited by 6
Wang, R., Ding, Q., de Assuncao, T. M., Mounajjed, T., Maiers, J. L., Dou, C., Cao, S., Yaqoob, U., Huebert, R. C., & Shah, V. H. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.001 · Cited by 6
Regulation of Mesothelial Cell Fate during Development and Human Diseases
Taniguchi, T., Tomita, H., Kanayama, T., Mogi, K., Koya, Y., Yamakita, Y., Yoshihara, M., Kajiyama, H., & Hara, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911960 · Cited by 6
Myofibroblast Functions in Tissue Repair and Fibrosis: An Introduction
Thannickal, V. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_2 · Cited by 6
Karsdal, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809847-9.02001-8 · Cited by 6
Li, W., Sparks, R. P., Sun, C., Yang, Y., Pantano, L., Kirchner, R., Arghiani, N., Weilheimer, A., Toles, B. J., Chen, J. Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56900-z · Cited by 5
Schonfeld, M., Nataraj, K., Mah, S., Weinman, S., & Tikhanovich, I. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101525 · Cited by 5
Cdc42 is crucial for the early regulation of hepatic stellate cell activation
Yuasa, H., Matsubara, T., Urushima, H., Daikoku, A., Ikenaga, H., Kadono, C., Kinoshita, M., Kimura, K., Ishizawa, T., Ohta, K., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00987.2024 · Cited by 5
Utilising an in silico model to predict outcomes in senescence-driven acute liver injury
Ashmore‐Harris, C., Antonopoulou, E., Aird, R. E., Man, T. Y., Finney, S. M., Speel, A. M., Lu, W., Forbes, S. J., Gadd, V. L., & Waters, S. L. (2024) · npj Regenerative Medicine · doi:10.1038/s41536-024-00371-1 · Cited by 5
An anti-RAGE chimeric antibody alleviates CCl4-induced liver fibrosis via RAGE/NF-kB pathway in mice
Liu, J., Li, H., Chen, H., Xiao, X., Jin, Z., Paerhati, P., Bao, W., Cui, C., Zhu, J., & Yuan, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117737 · Cited by 5
Zhang, J., Zao, X., Zhang, J., Guo, Z., Jin, Q., Chen, G., Gan, D., Du, H., & Ye, Y. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109627 · Cited by 5
Structure, Function and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 5
Suflețel, R. T., Melincovici, C. S., Orasan, O. H., Zaharie, T., Gheban, B., Istrate, A., Constantin, A.-M., & Mihu, C. M. (2023) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4726 · Cited by 5
TET1 inhibits liver fibrosis by blocking hepatic stellate cell activation
Wang, J., Zhang, Y., Ma, Y., Zhao, S., Wang, J., Chen, H., Zhang, J., & Liu, J. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16443 · Cited by 5
Extracellular Matrix Metabolism and Fibrotic Disease
Campana, L., & Iredale, J. P. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0058-7 · Cited by 5
Liver Fibrosis: Current Approaches and Future Directions for Diagnosis and Treatment
Chen, J. Y., Thakar, D., & Chang, T. T. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_15 · Cited by 5
Bansal, M. B., & Friedman, S. L. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch6 · Cited by 5
Mechanisms of Collagen Network Organization in Response to Tissue/Organ Damage
Saneyasu, T., Yoshioka, S., & Sakai, T. (2016) · InTech eBooks · doi:10.5772/63163 · Cited by 5
Emerging roles of DJ-1 in liver diseases through regulation of oxidative stress and immune response
Xu, M., Chen, L., Li, J., Wu, H., Xia, Q., & Kong, X. (2018) · Liver Research · doi:10.1016/j.livres.2018.06.001 · Cited by 5
Novel perspectives on the origins of the hepatic myofibroblasts
Kisseleva, T., Xu, J., Liu, X., & Brenner, D. A. (2015) · Cell Health and Cytoskeleton · doi:10.2147/chc.s57679 · Cited by 5
Self-citationMoscoso, C. G., & Steer, C. J. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s213397 · Cited by 5
Reply to: “Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice”
Liu, Y., Xu, N., & Ji, H. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.014 · Cited by 5
Pericytes in the Pulmonary Microenvironment: Guardians or Adversaries?
Lin, Y., Chen, J., Tan, J.-L., Yu, Z., Pi, R., Xiong, J., Ding, Y., Chen, M., & Bai, X. (2025) · Lung · doi:10.1007/s00408-025-00820-8 · Cited by 4
Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells
Wang, X., Ha, E. H., Bian, L., Feng, Z., Zhang, F., O’Shaughnessy, K., Wang, L., Hochwald, A., Zheng, Y., Chen, W., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101669 · Cited by 5
Islam, M. A., Mawya, J., Salma, U., Kasim, N. H. A., & Haque, N. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i11.111090 · Cited by 4
Chen, S., Gao, J., Chen, J., Huang, Y., Wang, L., Lin, J., Zhao, M., Shen, Y., Zhao, G., & Cheng, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147642 · Cited by 4
KLF4 Inhibits the Activation of Human Hepatic Stellate Cell In Vitro
Yang, X., Chen, Z., Tan, J., Xue, Y., & Zheng, H. (2024) · Current Medical Science · doi:10.1007/s11596-024-2860-8 · Cited by 4
Ravikumar, L., Velmurugan, R., Helinto, J. S., Yokesh, S., Divya, B., Harshitha, G. S., Harish Kanna, S., & Devaraji, M. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100594 · Cited by 4
p62 in Liver Disease: Good Guy or Bad Guy?
Hu, Z., & Zender, L. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.013 · Cited by 4
Zhao, J., Jiang, Y., Sun, X., Liu, X.-S., Liu, F., Song, M., & Zhang, L. (2020) · Bioscience Reports · doi:10.1042/bsr20193385 · Cited by 4
Zhao, H., Zhu, H., Zhang, Y., Ding, Y., Feng, R., Li, J., Ma, T., & Huang, C. (2023) · Inflammation · doi:10.1007/s10753-023-01831-4 · Cited by 4
The Stressful Life of Cardiac Myofibroblasts
Zimina, E., & Hinz, B. (2015) · Springer eBooks · doi:10.1007/978-3-319-17437-2_5 · Cited by 4
Adult Hepatic Progenitor Cells
Vestentoft, P. S. (2014) · InTech eBooks · doi:10.5772/58814 · Cited by 4
Chronic Liver Failure and Hepatic Cirrhosis
Grinspan, L. T., & Verna, E. C. (2018) · Springer eBooks · doi:10.1007/978-3-319-64298-7_2 · Cited by 4
Force-Bioreactor for Assessing Pharmacological Therapies for Mechanobiological Targets
Scholp, A. J., Jensen, J., Chinnathambi, S., Atluri, K., Mendenhall, A., Fowler, T. P., Salem, A. K., Martin, J. A., & Sander, E. A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.907611 · Cited by 4
The Rule‐Based Model Approach: A Kappa Model for Hepatic Stellate Cells Activation by TGFB1
Bouguéon, M., Boutillier, P., Ferêt, J., Hazard, O., & Théret, N. (2022) · Wiley eBooks · doi:10.1002/9781119716600.ch4 · Cited by 4
Hepatic Stellate Cells as Target for Reversal of Fibrosis/Cirrhosis
Lotersztajn, S., & Mallat, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800134-9.00011-7 · Cited by 4
Hepatic Fibrosis in Hepatitis C
Sheiko, M. A., & Rosen, H. R. (2016) · Springer eBooks · doi:10.1007/978-4-431-56101-9_3 · Cited by 4
Recent advances in small molecule design strategies against hepatic fibrosis
Chen, H., Su, W., Li, T., Wang, Y., Li, Z., Xiong, L., Chen, Z., Zhang, C., & Wang, T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117281 · Cited by 3
Zeng, C., Lu, Q., Zhao, Q., & Li, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08312-w · Cited by 3
Александровна, Д. И., Velikorodnaya, Y. I., Zagrebin, V. L., Сергеевич, Б. Л., & Smirnov, A. V. (2024) · Journal of Anatomy and Histopathology · doi:10.18499/2225-7357-2024-13-2-16-23 · Cited by 3
No significant impact of Foxf1 siRNA treatment in acute and chronic CCl 4 liver injury
Abshagen, K., Rotberg, T., Genz, B., & Vollmar, B. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217716425 · Cited by 3
Perveen, R., Ozaki, I., Manirujjaman, M., Mine, K., Murata, Y., Tanaka, K., Xia, J., Takahashi, H., Anzai, K., & Matsuhashi, S. (2022) · Human Cell · doi:10.1007/s13577-022-00844-9 · Cited by 3
Mungamuri, S. K., Chatterjee, N., & Ara, D. (2025) · Liver international communications. · doi:10.1002/lci2.70015 · Cited by 3
Mechanical and Matrix Regulation of Valvular Fibrosis
Blaser, M. C., & Simmons, C. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-17437-2_3 · Cited by 3
Recent advances in pediatric gastroenterology, hepatology and nutrition
Barnard, J. A. (2013) · F1000Prime Reports · doi:10.12703/p5-25 · Cited by 3
The Immunopathogenesis of Cirrhosis
Gao, B., Friedman, S. L., & Mehal, W. Z. (2013) · Springer eBooks · doi:10.1007/978-3-319-02096-9_28 · Cited by 4
Portal Hypertension—Molecular Mechanisms
Vorobioff, J., & Groszmann, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00034-5 · Cited by 3
Targeting Pericytes to Improve Wound Healing Outcomes
Bodnar, R. J., & Satish, L. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0168-8 · Cited by 3
Resolution to Inflammation: Its Role in Reducing Fibrosis and Tissue Repair
Meiliana, A., & Wijaya, A. (2023) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v15i2.2181 · Cited by 3
Parsani, H. R., Shyma, K. P., Patel, J. A., Chaudhary, N. R., & Patel, M. K. (2023) · International Journal of Bio-resource and Stress Management · doi:10.23910/1.2023.3397a · Cited by 3
Hedgehog signaling in the liver
Machado, M. V., & Diehl, A. M. (2015) · Wiley eBooks · doi:10.1002/9781118663387.ch19 · Cited by 3
Fra, Fra Away: The complex role of activator protein 1 in liver injury
Brenner, D. A. (2013) · Hepatology · doi:10.1002/hep.26637 · Cited by 3
Self-citationPathophysiological responses in chronic liver injury induced by thioacetamide
Gratte, F. D. (2021) · Murdoch University Research Portal · Cited by 3
Rare Gli1+ perivascular fibroblasts promote skin wound repairPreprint
Sun, X., Annusver, K., Dalessandri, T., & Kasper, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.16.491785 · Cited by 3
The interplay between biomechanics and cell kinetics explains the spatial pattern in liver fibrosisPreprint
Zhao, J., Hammad, S., de Langlard, M., Erdoesi, P., Li, Y., Liedekerke, P. V., Buttenschön, A., Winkler, M., Kürschner, S. W., Reiners-Koch, P.-S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.31.667562 · Cited by 3
Shawky, H. A., Ahmed, N. M., Essawy, M. M., & Basha, S. M. A. (2024) · The Journal of Contemporary Dental Practice · doi:10.5005/jp-journals-10024-3725 · Cited by 2
Thottappillil, N., Corselli, M., Murray, I., Hardy, R., Gomez-Salazar, M. A., Casamitjana, J., Shaw, I., Wang, Z., Vezzani, B., Ding, L., et al. (2025) · Vascular Pharmacology · doi:10.1016/j.vph.2025.107533 · Cited by 2
Proliferation of activated hepatic stellate cells requires REST
Shavva, V. S., Tarnawski, L., Dai, W., Moruzzi, N., Haller, A.-S., Borg, F., Hansson, S., Guo, Q., Cai, M., Fekete, E., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-025-01406-z · Cited by 2
Assessment of nanoindentation protocols for murine skin matrix biomechanics
FORSTER, L. S., Gavara, N., Rognoni, E., & Gupta, H. S. (2026) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2026.107381 · Cited by 2
Unraveling the pleiotropic effects of CCR2-dependent signal transduction in fibrosis development
Sun, G., Wang, J., Tang, J., Chen, M., Zhang, Z., Zhao, H., Jin, Z., Xu, X., Yang, Y., & Liu, J. (2026) · Theranostics · doi:10.7150/thno.130426 · Cited by 2
Foster, D. G., Javkhlan, N., Black, B. P., Vestal, B. E., Riches, D. W. H., & Redente, E. F. (2026) · JCI Insight · doi:10.1172/jci.insight.199660 · Cited by 2
Fallowfield, J. A., Ramachandran, P., & Kendall, T. J. (2026) · Journal of Hepatology · doi:10.1016/j.jhep.2026.05.026 · Cited by 2
Mosallanejad, K., Hubeau, C., Sterman, A. S., & Tan, Y. (2026) · Cells · doi:10.3390/cells15151412 · Cited by 4
Discoidin Domain Receptors in Liver Fibrosis
Olaso, E., Márquez, J., Benedicto, A., Badiola, I., & Arteta, B. (2016) · Springer eBooks · doi:10.1007/978-1-4939-6383-6_16 · Cited by 2
Leading-Edge Approaches for In Vitro Hepatotoxicity Evaluation
LeCluyse, E. L., Norona, L. M., Akingbasote, J. A., Howell, L. S., Woodhead, J. L., Cross, M. J., Roth, A. B., & Goldring, C. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64267-8 · Cited by 2
Pringle, T. A., Ramon‐Gil, E., Leslie, J., Oakley, F., Wright, M. C., Knight, J. C., & Luli, S. (2024) · Scientific Reports · doi:10.1038/s41598-023-50779-w · Cited by 2
Hepatic stellate cells activation and liver fibrosis after chronic administration of ethanol
Kot-Bakiera, K., Wawryk‐Gawda, E., Cichacz-Kwiatkowska, B., & Jodłowska‐Jędrych, B. (2016) · Current Issues in Pharmacy and Medical Sciences · doi:10.1515/cipms-2016-0014 · Cited by 2
Регенерация печени млекопитающих: межклеточные взаимодействия
Ельчанинов, А. В., & Fatkhudinov, T. (2020) · Наука eBooks · doi:10.7868/9785020407770 · Cited by 2
Profiles of messenger RNAs and MicroRNAs in hypoxia-induced hepatic stellate cells
Zhang, L., Gao, J., Zhou, D., Wang, X., Li, J., Wang, J., Chen, H., Xie, X., & Chen, T. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4215 · Cited by 2
Liver fibrosis: Our evolving understanding
Wells, R. G. (2024) · Clinical Liver Disease · doi:10.1097/cld.0000000000000243 · Cited by 2
Chronic Nanoplastic Exposure as a Novel Risk Amplifier for MASLD Progression
Guan, J., Ji, Y., & Chen, M. (2025) · Liver International · doi:10.1111/liv.70266 · Cited by 2
Zhang, Z., Zeng, C., Yong, X. N., Zhou, W., Xie, Y., & Shu, J. (2025) · Genes · doi:10.3390/genes16101213 · Cited by 2
Molecular basis of liver disease
Monga, S. P., & Behari, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813257-9.00020-6 · Cited by 2
Down-regulation of hepatic MBOAT7 by hyperinsulinemia favors steatosis development
Meroni, M., Dongiovanni, P., Rametta, R., Bassani, G. A., Badiali, S., Fargion, S. R., Romeo, S., Gatti, S., & Valenti, L. V. C. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31627-6 · Cited by 2
Portal Fibroblast Role in Liver Fibrosis in Rats
Abdu, S. B. S., & Al-, F. M. (2018) · International Journal of Pharmacology · doi:10.3923/ijp.2018.717.726 · Cited by 2
Myofibroblast differentiation in hypoxia: a novel role for ArhGAP29
Leinhos, L. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7454 · Cited by 2
Wang, S., & Friedman, S. L. (2020) · Hepatology · doi:10.1002/hep.31151 · Cited by 2
Mechanisms of activated hepatic stellate cell removal in acute and chronic liver injury
Hassan, R., & Justus Liebig University Giessen (2017) · University writing server of the Justus Liebig University Giessen (Justus-Liebig-Universität Gießen) · doi:10.22029/jlupub-11237 · Cited by 3
Fibrose hépatique : Les myofibroblastes en question
Housset, C. (2017) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30457-1 · Cited by 1
Metadata
- Authors
- Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., Evans, S. M., Dillmann, W., Glass, C. K., & Brenner, D. A.
- Affiliations
- Department of Medicine,
- Universitätsklinikum Aachen (DE)
- Department of Cellular and Molecular Medicine,
- School of Pharmacy, University of California, San Diego, CA 92093;
- University of Southern California (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-05-07
- Volume
- 109
- Issue
- 24
- Pages
- 9448-9453
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3386114
- OpenAlex
- W2075290880
- Cited by
- 805
- References
- 27
- Citations by year
- 2026: 29 · 2025: 51 · 2024: 61 · 2023: 59 · 2022: 53 · 2021: 62 · 2020: 64 · 2019: 52 · 2018: 53 · 2017: 61 · 2016: 64 · 2015: 73 · 2014: 63 · 2013: 42 · 2012: 13
- FWCI
- 38.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM041804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- myofibroblasts, hepatic stellate cells, liver fibrosis, fibrosis regression, apoptosis, anti-apoptotic genes, carbon tetrachloride, alcohol-induced liver injury, fibrogenic gene expression
- MeSH terms
- Animals, Liver Cirrhosis, Phenotype, Tamoxifen, Adoptive Transfer, Collagen Type I, Mice, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.